Zimmer Biomet Holdings has named Jonathan Vigdorchik, MD, as chief science, technology and medical affairs officer, effective April 14.
Dr. Vigdorchik will oversee the company’s global technology portfolio, including AI, robotics, smart implants and data, as well as its medical education strategy and global advisory board, according to an April 7 news release.
He previously served as Zimmer Biomet’s chief medical technology advisor for adult reconstruction and hip implants. He will report to Ivan Tornos, chairman, president and CEO.
Dr. Vigdorchik is also an orthopedic surgeon at Hospital for Special Surgery in New York City, where he specializes in hip and knee replacement surgery.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
